These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3058131)
1. Bronchospasmolytic effects of salbutamol as powder inhalation in patients with reversible bronchial obstruction. Deenstra M; Zanen P; Gusdorf CF Arzneimittelforschung; 1988 Oct; 38(10):1490-1. PubMed ID: 3058131 [TBL] [Abstract][Full Text] [Related]
2. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. Baronti A; Grieco A; Vibelli C Eur J Respir Dis; 1980 Jun; 61(3):143-50. PubMed ID: 7002574 [TBL] [Abstract][Full Text] [Related]
3. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol. Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer. Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619 [TBL] [Abstract][Full Text] [Related]
5. Comparison of bronchodilating effects of two salbutamol dry powder inhalers in asthmatic patients. Laurikainen K; Silvasti M; Calderon P; Lins R; Rosillon D Arzneimittelforschung; 1997 Jan; 47(1):44-6. PubMed ID: 9037443 [TBL] [Abstract][Full Text] [Related]
6. Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients. Hartley JP; Nogrady SG; Seaton A Br J Dis Chest; 1979 Jul; 73(3):271-6. PubMed ID: 399858 [TBL] [Abstract][Full Text] [Related]
7. A novel multiple dose powder inhaler. Salbutamol powder and aerosol give equal bronchodilatation with equal doses. Haahtela T; Vidgren M; Nyberg A; Korhonen P; Laurikainen K; Silvasti M Ann Allergy; 1994 Feb; 72(2):178-82. PubMed ID: 8109809 [TBL] [Abstract][Full Text] [Related]
8. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. Lindberg A; Szalai Z; Pullerits T; Radeczky E Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063 [TBL] [Abstract][Full Text] [Related]
9. A comparison of albuterol and metaproterenol nebulizer solutions. Habib MP; Campbell SC; Shon BY; Pinnas JL Ann Allergy; 1987 Jun; 58(6):421-4. PubMed ID: 3296867 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma]. Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530 [TBL] [Abstract][Full Text] [Related]
11. [The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis]. Vestri R; Philip-Joet F; Reynaud-Gaubert M; Arnaud A Rev Mal Respir; 1990; 7(1):59-63. PubMed ID: 2251437 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of the bronchospasmolytic effect of fenoterol (0.2 mg) salbutamol (0.4 mg) as powder inhalations in 20 patients with reversible bronchial obstruction. Maesen FP; Smeets JJ; Bernsen R; Cornelissen PJ Respiration; 1984; 45(3):265-70. PubMed ID: 6379788 [TBL] [Abstract][Full Text] [Related]
13. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation. Chege JK; Chrystyn H Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner. Kawai M; Sakai A; Takaori S; Hiura A; Sakata N; Nakashima M; Miyamoto T Methods Find Exp Clin Pharmacol; 2005; 27(6):385-9. PubMed ID: 16179955 [TBL] [Abstract][Full Text] [Related]
15. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma. Beskow R; Ericsson CH; Grönneberg R; Sjögren I; Skedinger M Eur J Respir Dis; 1984 Oct; 65(7):509-11. PubMed ID: 6386512 [TBL] [Abstract][Full Text] [Related]
16. Fenoterol administered as an inhaled powder. A comparison with salbutamol powder. Hey AA; Gillies AJ N Z Med J; 1985 Feb; 98(772):74-5. PubMed ID: 3883254 [No Abstract] [Full Text] [Related]
17. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease]. Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854 [TBL] [Abstract][Full Text] [Related]
18. Salbutamol in the treatment of asthmatic children. A comparison of oral and inhalation therapy alone and in combination. Berg IM; Berg T; Ringqvist I Eur J Respir Dis; 1982 Jul; 63(4):305-9. PubMed ID: 7117428 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction. Carlsson LG; Arweström E; Friberg K; Källén A; Lunde H; Löfdahl CG Allergy; 1998 Jul; 53(7):712-5. PubMed ID: 9700042 [TBL] [Abstract][Full Text] [Related]
20. Salbutamol powder inhaled from the Diskhaler compared to salbutamol as nebulizer solution in severe chronic airways obstruction. Hansen NC; Andersen PB Respir Med; 1995 Mar; 89(3):175-9. PubMed ID: 7746909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]